prikaz prve stranice dokumenta Genomics in multiple sclerosis
  Download
PDF 191.32 KB
Scientific paper - Review paper
Genomics in multiple sclerosis
Clinical Neurology and Neurosurgery, 112 (2010), 7; 621-624. https://doi.org/10.1016/j.clineuro.2010.03.028
Habek, Mario; Borovečki, Fran; Brinar, Vesna V.

Cite this document

Habek, M., Borovečki, F. & Brinar, V. V. (2010). Genomics in multiple sclerosis. Clinical Neurology and Neurosurgery, 112. (7), 621-624. doi: 10.1016/j.clineuro.2010.03.028

Habek, Mario, et al. "Genomics in multiple sclerosis." Clinical Neurology and Neurosurgery, vol. 112, no. 7, 2010, pp. 621-624. https://doi.org/10.1016/j.clineuro.2010.03.028

Habek, Mario, Fran Borovečki and Vesna V. Brinar. "Genomics in multiple sclerosis." Clinical Neurology and Neurosurgery 112, no. 7 (2010): 621-624. https://doi.org/10.1016/j.clineuro.2010.03.028

Habek, M., Borovečki, F. and Brinar, V. V. (2010) 'Genomics in multiple sclerosis', Clinical Neurology and Neurosurgery, 112(7), pp. 621-624. doi: 10.1016/j.clineuro.2010.03.028

Habek M, Borovečki F, Brinar VV. Genomics in multiple sclerosis. Clinical Neurology and Neurosurgery [Internet]. 2010 September [cited 2024 November 09];112(7):621-624. doi: 10.1016/j.clineuro.2010.03.028

M. Habek, F. Borovečki and V. V. Brinar, "Genomics in multiple sclerosis", Clinical Neurology and Neurosurgery, vol. 112, no. 7, pp. 621-624, September 2010. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:975777. [Accessed: 09 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Genomics in multiple sclerosis
AuthorMario Habek
AuthorFran Borovečki
AuthorVesna V. Brinar
Author's institutionUniversity of Zagreb
School of Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
Multiple sclerosis (MS) is chronic, inflammatory disease of the central nervous system that mainly affects young adults and is characterized with dissemination of demyelinating lesions in time and space. It is well known that MS is very heterogeneous disease, so biomarkers that would reliably determine disease course, outcome or treatment response in early stages of the disease (preferentially clinically isolated syndrome) are desperately needed. Genome-wide expression analysis represents the profile of all genes in a certain tissue or cell population in a certain time point. Therefore, as the sequence of the human genome is entirely known, it is possible to analyze any given human gene in any given context. This review will discuss results and possible applications of genome-wide expression studies in brain tissue and blood samples of MS patients.
Keywords (english)
Languageenglish
Publication typeScientific paper - Review paper
Publication statusPublished
Peer reviewPeer review
Publication versionAccepted version
Journal titleClinical Neurology and Neurosurgery
Numberingvol. 112, no. 7, pp. 621-624
p-ISSN0303-8467
DOIhttps://doi.org/10.1016/j.clineuro.2010.03.028
URN:NBNurn:nbn:hr:105:975777
Publication2010-09
Document URLhttps://doi.org/10.1016/j.clineuro.2010.03.028
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2024-03-28 11:45:02